Clearmind Medicine在印度提交新一代迷幻化合物专利申请,瞄准精神健康障碍治疗

美股速递
Mar 27

Clearmind Medicine, Inc. 已正式向印度提交专利申请,针对其研发的新一代迷幻化合物,旨在用于治疗各类精神健康障碍。这一举措标志着该公司在拓展全球知识产权布局方面迈出关键一步,为其创新疗法在潜在巨大市场的应用奠定基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10